课题基金 / 基金详情

Cross talk between oncogene and ant-oncogene via the Crk oncogene product

Cross talk between oncogene and ant-oncogene via the Crk oncogene product
通过 Crk 癌基因产品实现癌基因和抗癌基因之间的交互
批准号:
10470064
负责人:
MATSUDA Michiyuki
金额:
$8.51万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

MATSUDA Michiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
Crk癌基因产物激活Ras和Rap1。Ras是一种众所周知的致癌基因,而Rap1可以拮抗Ras依赖性的肿瘤发生。为了了解Crk激活癌基因和抗癌基因的机制,我们开发了一种基于fret的单分子探针,可以监测活细胞中Crk的激活。使用这种探针,我们看到了egf刺激细胞中Crk的快速激活。然而,由于探针的快速扩散,我们无法确定细胞中Crk的激活是从哪里开始的。为了克服这一缺陷,我们将Ki-Ras蛋白的CAAX盒与探针融合,期望探针能锚定在质膜上。事实上,通过使用这种caax融合探针,我们发现Crk从细胞的外周区域被激活。此外,我们构建了一种重组腺病毒来表达探针,使我们能够在多种细胞中快速有效地表达探针。因此,新的Crk活性探针的开发,可视化了Crk癌基因产物在活细胞中的时空调控,为我们理解Crk癌基因产物在细胞生长和转化中的调控作用提供了基础。
英文摘要
Crk oncogene product activates Ras and Rap1. Ras is a well-known oncogene, whereas Rap1 antagonize Ras-dependent oncogenesis. To understand the mechanism by which Crk activates both oncogene and anti-oncogene, we developed a FRET-based single-molecule probe that can monitor the activation of Crk in a living cell. Using this probe, we visualized rapid Crk activation in an EGF-stimulated cell. However, with the prototype probe, we could not determine where in the cell the activation of Crk starts, due to rapid diffusion of the probe. To overcome this flaw, we fused CAAX box of Ki-Ras protein to the probe, expecting the anchoring of probe to the plasma membrane. Indeed, by the use of this CAAX-fused probe, we found that Crk was activated from the peripheral region of the cell. Furthermore, we generated a recombinant adenovirus for the expression of the probe, which enabled us rapid and efficient expression of the probe in a variety of cells. Thus, the development of new probe for the Crk activity visualized the spatio temporal regulation of Crk oncogene products in living cells and promised us for the understanding of the role of Crk oncogene products in the regulation of cell growth and transformation.
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
Hasegawa H,et al: "DOCK180,a major CRK-binding protein,alters cell morphology upon translocation to the membrane." Mol Cell Biol. 16. 1770-1776 (1996)
Hasekawa H 等人:“DOCK180 是一种主要的 CRK 结合蛋白,在易位到膜上后会改变细胞形态。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Kurakawa, et al.: "A Pair of Fluorescent Resonance Energy Transfer-based Probes for Tyrosine phosphorylation of the CrkII Adaptor Protein in Vivo."J. Boil Chem.. 276. 31305-31310 (2001)
K.Kurakawa 等人:“一对基于荧光共振能量转移的探针,用于体内 CrkII 衔接蛋白的酪氨酸磷酸化”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 35 条
    Spatio-temporal analysis of small GTPases involved in vesicular trafficking by fluorescence imaging
    • 批准号:
      19209008
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.79万
    • 财政年份:
      2007
    • 负责人:
      MATSUDA Michiyuki
    • 依托单位:
    Analysis on the spatio-temporal regulation of cellular oncogenesis
    Spatiotemporal regulation of Rho-family GTPases
    Imaging of Ras-MAP kinase signal transduction cascade
    • 批准号:
      16025201
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $19.2万
    • 财政年份:
      2004
    • 负责人:
      MATSUDA Michiyuki
    • 依托单位:
    国内基金
    海外基金
    基于FRET机制的增强型NIR-II荧光脂质体的设计及其生物应用
    基于核素激活TET-FRET双路径能量传递的杂化纳米体系用于肿瘤内照射放射动力-免疫协同治疗的研究
    利用活细胞超分辨定量FRET成像技术研 究ROCK调控细胞间隧道纳米管形成机制 及其功能
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      陈鸿策
    • 依托单位:
    基于活细胞FRET显微成像的肝癌治疗药物评价方法
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      吴宝艳
    • 依托单位: